Skip to main content
Article
Health effects of the Federal Bureau of Prisons tobacco ban
Open Access Articles
  • Stephen A. Martin, University of Massachusetts Medical School
  • Bartolome R. Celli, Harvard Medical School
  • Joseph R. DiFranza, University of Massachusetts Medical School
  • Stephen J. Krinzman, University of Massachussetts Medical School
  • Jennifer G. Clarke, Warren Alpert Brown University Medical School
  • Herbert Beam, Federal Medical Center
  • Sandra Howard, Federal Medical Center
  • Melissa Foster, University of Massachusetts Medical School
  • Robert J. Goldberg, University of Massachusetts Medical School
UMMS Affiliation
Department of Quantitative Health Sciences; Meyers Primary Care Institute; Department of Family Medicine and Community Health; Department of Medicine, Division of Pulmonary and Critical Care Medicine
Date
10-15-2012
Document Type
Article
Subjects
Tobacco; Smoking; Smoking Cessation; Tobacco Use Cessation; Prisoners; Lung Diseases; Asthma
Abstract

BACKGROUND: Tobacco smoking remains the leading cause of preventable death in America, claiming 450,000 lives annually. Chronic Obstructive Pulmonary Disease, caused by smoking in the vast majority of cases, became the third leading cause of death in the U.S. in 2008. The burden of asthma, often exacerbated by tobacco exposure, has widespread clinical and public health impact. Despite this considerable harm, we know relatively little about the natural history of lung disease and respiratory impairment in adults, especially after smoking cessation.

METHODS/DESIGN: Our paper describes the design and rationale for using the 2004 Federal Bureau of Prisons tobacco ban to obtain insights into the natural history of respiratory diseases in adult men and women of different races/ethnicities who are imprisoned in federal medical facilities. We have developed a longitudinal study of new prison arrivals, with data to be collected from each participant over the course of several years, through the use of standardized questionnaires, medical chart reviews, lung function tests, six-minute walk tests, and stored serum for the analysis of present and future biomarkers. Our endpoints include illness exacerbations, medication and health services utilization, lung function, serum biomarkers, and participants' experience with their health and nicotine addiction.

DISCUSSION: We believe the proposed longitudinal study will make a substantial contribution to the understanding and treatment of respiratory disease and tobacco addiction.

Comments

Citation: BMC Pulm Med. 2012 Oct 15;12:64. doi: 10.1186/1471-2466-12-64. Link to article on publisher's site

© 2012 Martin et al.; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related Resources
Link to Article in PubMed
PubMed ID
23067295
Citation Information
Stephen A. Martin, Bartolome R. Celli, Joseph R. DiFranza, Stephen J. Krinzman, et al.. "Health effects of the Federal Bureau of Prisons tobacco ban" Vol. 12 (2012) ISSN: 1471-2466 (Linking)
Available at: http://works.bepress.com/robert_goldberg/372/